LI
WST icon

LRI Investments’s West Pharmaceutical WST Stock Holding History

LRI Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.3K Buy
246
+4
+2% +$1.22K 0.01% 463
2026
Q1 		$60.7K Buy
242
+24
+11% +$5.97K 0.01% 487
2025
Q4 		$60K Hold
218
– – ﹤0.01% 511
2025
Q3 		$57.2K Hold
218
– – ﹤0.01% 529
2025
Q2 		$47.7K Hold
218
– – ﹤0.01% 559
2025
Q1 		$48.8K Hold
218
– – ﹤0.01% 535
2024
Q4 		$71.4K Hold
218
– – 0.01% 472
2024
Q3 		$73.7K Hold
218
– – 0.01% 467
2024
Q2 		$71.8K Hold
218
– – 0.01% 439
2024
Q1 		$86.3K Buy
+218
New +$80.6K 0.02% 219

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

LRI Investments's WST Position: Q2 2026 in Review

LRI Investments increased its West Pharmaceutical (WST) stake by 1.7% in Q2 2026, buying an estimated $1.22K and bringing the position to 246 shares worth $88.3K. The position accounts for 0.01% of the portfolio, ranked #463.

LRI Investments first reported a position in WST in Q1 2024 and has held it in 10 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • LRI Investments held 246 shares of West Pharmaceutical worth $88.3K as of Q2 2026.
  • LRI Investments bought 4 West Pharmaceutical shares in Q2 2026, an estimated $1.22K.
  • West Pharmaceutical made up 0.01% of LRI Investments's portfolio in Q2 2026, its #463 holding.
  • LRI Investments first reported a position in West Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.